Prospective analysis of 895 patients on a UK Genomics Review Board

More about Open Access at the Crick

Abstract

The increasing frequency and complexity of cancer genomic profiling represents a challenge for the oncology community. Results from next-generation sequencing-based clinical tests require expert review to determine their clinical relevance and to ensure patients are stratified appropriately to established therapies or clinical trials.